Man­u­fac­tur­ing roundup: Actylis opens the doors to a fa­cil­i­ty in Ore­gon; Emer­gent re­ports Q4 num­bers

The in­gre­di­ents man­u­fac­tur­er Actylis has opened a new 30,000-square-foot fa­cil­i­ty in the city of Eu­gene, OR.

Actylis CEO Gilles Cot­ti­er said in a state­ment the new site will al­low the com­pa­ny to man­u­fac­ture APIs and in­ter­me­di­ates for clin­i­cal tri­als — and on a com­mer­cial scale.

“We de­signed this fa­cil­i­ty specif­i­cal­ly to en­able us to de­vel­op and pro­duce in­no­v­a­tive APIs for our cus­tomers. Our in­ti­mate knowl­edge of their needs, our con­sul­ta­tive ap­proach, and our fo­cus on in­no­va­tion of­fer un­par­al­leled choice and flex­i­bil­i­ty,” Cot­ti­er added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER